Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma

被引:0
作者
J. Ni
T. Zhu
L. Zhao
F. Che
Y. Chen
H. Shou
A. Yu
机构
[1] Zhejiang Cancer Hospital,Department of Gynecologic Oncology
来源
Clinical and Translational Oncology | 2015年 / 17卷
关键词
Endometrial adenocarcinoma; Metabolic syndrome; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:835 / 839
页数:4
相关论文
共 107 条
[21]  
Rosato V(2008)A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 17 921-929
[22]  
Zucchetto A(2007)Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European Prospective Investigation into Cancer and Nutrition Int J Cancer 120 2656-2664
[23]  
Bosetti C(2004)Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer Int J Cancer 108 262-268
[24]  
Dal Maso L(2004)Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 579-591
[25]  
Montella M(2006)Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria Diabetologia 49 945-952
[26]  
Pelucchi C(undefined)undefined undefined undefined undefined-undefined
[27]  
Esposito K(undefined)undefined undefined undefined undefined-undefined
[28]  
Chiodini P(undefined)undefined undefined undefined undefined-undefined
[29]  
Colao A(undefined)undefined undefined undefined undefined-undefined
[30]  
Lenzi A(undefined)undefined undefined undefined undefined-undefined